The Vistria Group

Co-Chairmen and Co-CEOs Marty Nesbitt and Kip Kirkpatrick share leadership of the firm and are central to investment committee decisions. Nesbitt brings deep political and strategic relationships, while Kirkpatrick contributes extensive private equity operating experience from his prior roles at firms including Sterling Partners. The investment teams are sector-aligned, with each vertical led by a managing partner who has operating or policy background specific to that industry.

Vistria functions as a private equity fund manager but differs from traditional firms in its formal integration of impact measurement into its investment process. The firm maintains dedicated operating partners who track non-financial outcomes such as healthcare access, educational attainment, and job placement rates across portfolio companies. This impact framework is embedded in deal underwriting, not treated as a separate reporting layer.

Vistria targets middle-market buyouts and growth equity investments, with equity check sizes generally ranging from $50M to $300M. The firm invests in companies with established business models and recurring revenues, often in regulated or essential-service industries where operational expertise can unlock both financial performance and expanded social reach. It does not engage in early-stage venture capital or seed-stage investing.

Vistria focuses exclusively on healthcare services, education, financial services, and enterprise software. It does not invest in sectors it considers inconsistent with its impact mandate — notably avoiding fossil fuel extraction, weapons manufacturing, tobacco, and for-profit prisons. These exclusions are explicit in the firm's investment policy, as publicly communicated to limited partners.

Vistria routinely offers co-investment opportunities to its limited partners as part of its deal structuring, particularly for larger transactions that exceed the capacity of its flagship fund. The firm does not disclose a systematic program for co-investing alongside unaffiliated external GPs. Its model favors direct sourcing and lead sponsorship, which preserves full control over the impact-measurement process and post-close governance.